Treatment of obesity and/or diabetes through weight loss [82, 83], exercise, lifestyle intervention, bariatric surgery [82], or thiazolidinedione treatment [84] lowers serum RBP4 levels. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.